These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


124 related items for PubMed ID: 25787337

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design of tenofovir-UC781 combination microbicide vaginal gels.
    Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR.
    J Pharm Sci; 2012 May; 101(5):1852-64. PubMed ID: 22359356
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of a UC781 releasing polyethylene vinyl acetate vaginal ring.
    McConville C, Major I, Friend DR, Clark MR, Malcolm RK.
    Drug Deliv Transl Res; 2012 Dec; 2(6):489-97. PubMed ID: 25787327
    [Abstract] [Full Text] [Related]

  • 5. Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulations.
    Patton DL, Sweeney YT, Balkus JE, Rohan LC, Moncla BJ, Parniak MA, Hillier SL.
    Antimicrob Agents Chemother; 2007 May; 51(5):1608-15. PubMed ID: 17353240
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy, pharmacokinetics, and in vivo antiviral activity of UC781, a highly potent, orally bioavailable nonnucleoside reverse transcriptase inhibitor of HIV type 1.
    Buckheit RW, Hollingshead M, Stinson S, Fliakas-Boltz V, Pallansch LA, Roberson J, Decker W, Elder C, Borgel S, Bonomi C, Shores R, Siford T, Malspeis L, Bader JP.
    AIDS Res Hum Retroviruses; 1997 Jun 10; 13(9):789-96. PubMed ID: 9171223
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir.
    Murphy DJ, Desjardins D, Dereuddre-Bosquet N, Brochard P, Perrot L, Pruvost A, Le Grand R, Lagatie O, Vanhooren L, Feyaerts M, van Roey J, Malcolm RK.
    J Antimicrob Chemother; 2014 Sep 10; 69(9):2477-88. PubMed ID: 24862093
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Impact of ring size and drug loading on the pharmacokinetics of a combination dapivirine-darunavir vaginal ring in cynomolgus macaques.
    Murphy DJ, Desjardins D, Boyd P, Dereuddre-Bosquet N, Stimmer L, Caldwell A, Le Grand R, Kelly C, van Roey J, Malcolm RK.
    Int J Pharm; 2018 Oct 25; 550(1-2):300-308. PubMed ID: 30153490
    [Abstract] [Full Text] [Related]

  • 17. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action.
    Fetherston SM, Boyd P, McCoy CF, McBride MC, Edwards KL, Ampofo S, Malcolm RK.
    Eur J Pharm Sci; 2013 Feb 14; 48(3):406-15. PubMed ID: 23266465
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent.
    Balzarini J, Naesens L, Verbeken E, Laga M, Van Damme L, Parniak M, Van Mellaert L, Anné J, De Clercq E.
    AIDS; 1998 Jul 09; 12(10):1129-38. PubMed ID: 9677161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.